Promise of cancer stem cell vaccine

Dendritic cell (DC)-based vaccines designed to target cancer stem cells (CSC) can induce significant antitumor responses via conferring host anti-CSC immunity. Our recent studies have demonstrated that CSC-DC vaccine could inhibit metastasis of primary tumors and induce humoral immune responses agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Li, Lu, Lin, Wicha, Max S, Chang, Alfred E, Xia, Jian-chuan, Ren, Xiubao, Li, Qiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054775/
https://www.ncbi.nlm.nih.gov/pubmed/26337078
http://dx.doi.org/10.1080/21645515.2015.1083661
_version_ 1782458661818335232
author Zhou, Li
Lu, Lin
Wicha, Max S
Chang, Alfred E
Xia, Jian-chuan
Ren, Xiubao
Li, Qiao
author_facet Zhou, Li
Lu, Lin
Wicha, Max S
Chang, Alfred E
Xia, Jian-chuan
Ren, Xiubao
Li, Qiao
author_sort Zhou, Li
collection PubMed
description Dendritic cell (DC)-based vaccines designed to target cancer stem cells (CSC) can induce significant antitumor responses via conferring host anti-CSC immunity. Our recent studies have demonstrated that CSC-DC vaccine could inhibit metastasis of primary tumors and induce humoral immune responses against cancer stem cells. This approach highlights the promise of cancer stem cell vaccine in cancer immunotherapy.
format Online
Article
Text
id pubmed-5054775
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-50547752016-10-18 Promise of cancer stem cell vaccine Zhou, Li Lu, Lin Wicha, Max S Chang, Alfred E Xia, Jian-chuan Ren, Xiubao Li, Qiao Hum Vaccin Immunother Commentaries Dendritic cell (DC)-based vaccines designed to target cancer stem cells (CSC) can induce significant antitumor responses via conferring host anti-CSC immunity. Our recent studies have demonstrated that CSC-DC vaccine could inhibit metastasis of primary tumors and induce humoral immune responses against cancer stem cells. This approach highlights the promise of cancer stem cell vaccine in cancer immunotherapy. Taylor & Francis 2015-09-04 /pmc/articles/PMC5054775/ /pubmed/26337078 http://dx.doi.org/10.1080/21645515.2015.1083661 Text en © 2015 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Commentaries
Zhou, Li
Lu, Lin
Wicha, Max S
Chang, Alfred E
Xia, Jian-chuan
Ren, Xiubao
Li, Qiao
Promise of cancer stem cell vaccine
title Promise of cancer stem cell vaccine
title_full Promise of cancer stem cell vaccine
title_fullStr Promise of cancer stem cell vaccine
title_full_unstemmed Promise of cancer stem cell vaccine
title_short Promise of cancer stem cell vaccine
title_sort promise of cancer stem cell vaccine
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054775/
https://www.ncbi.nlm.nih.gov/pubmed/26337078
http://dx.doi.org/10.1080/21645515.2015.1083661
work_keys_str_mv AT zhouli promiseofcancerstemcellvaccine
AT lulin promiseofcancerstemcellvaccine
AT wichamaxs promiseofcancerstemcellvaccine
AT changalfrede promiseofcancerstemcellvaccine
AT xiajianchuan promiseofcancerstemcellvaccine
AT renxiubao promiseofcancerstemcellvaccine
AT liqiao promiseofcancerstemcellvaccine

Ejemplares similares